Nahdi Medical Company (4164.SR)

SAR 120.8

(0.0%)

Market Cap (In SAR)

15.7 Billion

Revenue (In SAR)

8.71 Billion

Net Income (In SAR)

892.61 Million

Avg. Volume

266.94 Thousand

Currency
SAR
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.0-156.8
PE
-
EPS
-
Beta Value
0.173
ISIN
SA15HG521213
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Yasser Gholam Abdulaziz Joharji
Employee Count
-
Website
https://www.nahdi.sa
Ipo Date
2022-04-18
Details
Nahdi Medical Company operates as a pharmaceutical retailer in the Kingdom of Saudi Arabia and the United Arab Emirates. The company offers pharmaceutical and health products, such as medicine, wellness, mom and baby, beauty, and other FMCG products. It also provides omni-health services through its polyclinics, express clinics, telemedicine, labs, and home healthcare. In addition, the company engages in the wholesale and retail trading of cosmetics, pharmaceutical products, special and healthy foods, and medical equipment. It operates approximately 1,151 pharmacies. The company was founded in 1986 and is headquartered in Jeddah, the Kingdom of Saudi Arabia. Nahdi Medical Company operates as a subsidiary of Alnahdi Holding Company Limited and Saudi Economic and Development Company Limited.

More Stocks